Ranked by engagement
Top topics — this quarter page 10
Ranked by replies, likes and views over this quarter, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
515 topics · page 10 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Revisiting: How this community labels and discusses unrefereed work
Revisiting: How this community labels and discusses unrefereed work Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
|
+31 | 35 | 7k | 1d |
|
Lipid changes during rapid weight loss: the expected trajectory
Posting this under the heading it deserves: Lipid changes during rapid weight loss: the expected trajectory Everything below is what sits behind that. General question, not a request for advice about my own…
|
+11 | 15 | 34k | 11h |
|
Bariatric surgery history: altered anatomy, altered expectations
Posting this under the heading it deserves: Bariatric surgery history: altered anatomy, altered expectations Everything below is what sits behind that. General question, not a request for advice about my own…
|
+35 | 39 | 486 | 2mo |
|
Solubility limits and what a cloudy solution is telling you
Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate…
|
+11 | 15 | 34k | 20h |
|
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset
Posting this under the heading it deserves: Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022)…
|
+27 | 31 | 17k | 25d |
|
Journal club: semaglutide in MASH, and surrogate endpoints
Posting this under the heading it deserves: Journal club: semaglutide in MASH, and surrogate endpoints Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with SURMOUNT-2 (…
|
+24 | 28 | 17k | 15h |
|
Risk-of-bias tools and the judgement they conceal — does this still hold?
Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
|
+26 | 30 | 5.8k | 23h |
|
Semaglutide formulation: what is in the licensed product besides the peptide
Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-1 ( N…
|
+29 | 35 | 4.4k | 1h |
|
Reading U-100 graduations, with a conversion table
Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. Practical question with the units stated, because I have seen how…
|
+35 | 41 | 2k | 1d |
|
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+4 | 8 | 38k | 6h |
|
Two scans six weeks apart on different machines: a cautionary tale
On the subject in the title: Two scans six weeks apart on different machines: a cautionary tale Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a…
|
+18 | 26 | 9.4k | 2mo |
|
A revision dispute resolved on the topic rather than in the history
A revision dispute resolved on the topic rather than in the history Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation…
|
+11 | 15 | 40k | 16h |
|
About the Syringes & needles category
Insulin syringe graduations, dead volume, gauge and length selection, and reading units correctly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 45k | 1mo | |
|
What the GIP component of tirzepatide is thought to contribute, and how confident we can be
What the GIP component of tirzepatide is thought to contribute, and how confident we can be I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing STEP 1 ( N Engl…
|
+16 | 20 | 23k | 19h |
|
What a certificate commits its issuer to — the long version
Asking directly, because I could not find a straight answer: What a certificate commits its issuer to — the long version A documentation question rather than an analytical one. I have a certificate in front…
|
+20 | 26 | 21k | 2d |
|
Request declined, with reasoning — what changed since
Posting this under the heading it deserves: Request declined, with reasoning — what changed since Everything below is what sits behind that. Process question about how this site works. I have read the…
|
+34 | 38 | 9.4k | 2mo |
|
Why cagrilintide alone is discussed so much less than in combination — does this still hold?
Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4…
|
+27 | 31 | 1.2k | 22h |
|
Recording a dissent on a document rather than suppressing it
Recording a dissent on a document rather than suppressing it Writing it up because I had to work it out twice and would rather nobody else did. Process question about how this site works. I have read the…
|
+15 | 19 | 25k | 1mo |
|
Personal or family history of medullary thyroid carcinoma
Personal or family history of medullary thyroid carcinoma Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+31 | 37 | 709 | 26d |
|
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024)…
|
+7 | 11 | 31k | 19h |
|
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one year on
Asking directly, because I could not find a straight answer: Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one year on I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited…
|
+16 | 20 | 18k | 2mo |
|
About the Receptor biology category
GLP-1, GIP, glucagon and amylin receptor signalling, bias, desensitisation and central versus peripheral action. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
|
+6 | 10 | 34k | 20d |
|
How this community labels and discusses unrefereed work — the long version
Asking directly, because I could not find a straight answer: How this community labels and discusses unrefereed work — the long version I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a…
|
+18 | 23 | 21k | 2mo |
|
I have no scientific background — can I still follow the analytics categories?
The question in the title: I have no scientific background — can I still follow the analytics categories? I will give what I have already checked below so nobody repeats it. I want to check my reasoning…
|
+29 | 40 | 1.4k | 12d |
|
Introducing myself: pharmacist, sceptic, reluctant participant
Introducing myself: pharmacist, sceptic, reluctant participant Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still applies if…
|
+13 | 17 | 23k | 2mo |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold?
Asking directly, because I could not find a straight answer: How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Structured report rather than an opinion, following the…
|
+24 | 28 | 8k | 1mo |
|
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
|
+37 | 42 | 2.1k | 1d |
|
Validating a calculator against hand arithmetic
Validating a calculator against hand arithmetic Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+17 | 21 | 12k | 3mo |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of May 2026, in…
|
+10 | 14 | 27k | 2d |
|
Coming back to: Swirling versus inverting versus leaving it alone
Swirling versus inverting versus leaving it alone Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how quickly…
|
+20 | 24 | 16k | 26d |